Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radical Bromination and Chemoselective Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112645826B reveals a cost-effective 3-step synthesis for ethynyl aniline, offering significant supply chain advantages for oncology drug manufacturing.